News Daily News Statins Positively Alter Coronary Plaque Composition Michael O'Riordan August 23, 2021
News Daily News Statin Decisions Gain From Scoring of Coronary Artery Calcium: MESA Yael L. Maxwell July 21, 2021
News Daily News ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores Shelley Wood July 12, 2021
News Daily News OMT Boosts Survival in Revascularized Patients at 10 Years Michael O'Riordan June 29, 2021
News Daily News Statins Not Linked to Dementia or Memory Changes: ASPREE Michael O'Riordan June 21, 2021
News Daily News LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD Michael O'Riordan June 18, 2021
News Daily News Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors Michael O'Riordan June 16, 2021
News Daily News First PCIs Preceded by Many Modifiable Risk Factors: Registry Data L.A. McKeown June 16, 2021
News Conference News EAS 2021 For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short Michael O'Riordan June 03, 2021
News Daily News AHA: Physical Activity Should First-line Therapy as BP, LDL Tick Upwards Michael O'Riordan June 02, 2021
News Conference News ACC 2021 Evinacumab Lowers Triglycerides in Severe Hypertriglyceridemia Yael L. Maxwell May 16, 2021
News Conference News SCAI 2021 In African-American Patients, Nontraditional Risk Factors Track With Early CAD Michael O'Riordan April 28, 2021
News Daily News Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA Michael O'Riordan April 26, 2021
News Daily News In Female Veterans With Early ASCVD, Secondary Prevention Falls Short Michael O'Riordan April 21, 2021
News Features Roughly 80% of ESC Guideline Writers Have Financial COIs Michael O'Riordan April 01, 2021
News Daily News Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk Michael O'Riordan March 23, 2021
News Daily News Experts Fear Coronary CT Advice for Patients Misses the Mark Michael O'Riordan March 19, 2021
News Daily News Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval Michael O'Riordan March 03, 2021